Table 2 Circadian-enriched hormone and stress response pathways
Treatment | % Circadian (circadian/expressed [n]) | P value for over-representation | Other reports of enrichment of genes with | |
|---|---|---|---|---|
| Â | Â | Â | Diurnal regulation | Circadian regulation |
Abscisic acid (up) | 41% (492/1194) | 2.7 × 10-14 | [56] | - |
Abscisic acid (down) | 39% (500/1282) | 5.5 × 10-10 | [56] | - |
1-Aminocyclopropane-1-carboxylic acid (up) | 35% (36/103) | 0.25 | - | - |
1-Aminocyclopropane-1-carboxylic acid (down) | 42% (139/329) | 1.6 × 10-05 | - | - |
Brassinolide (up) | 35% (75/213) | 0.13 | - | [62] |
Brassinolide (down) | 45% (153/340) | 6.2 × 10-08 | - | - |
Cytokinin (up) | 38% (97/257) | 1.6 × 10-02 | - | - |
Cytokinin (down) | 45% (59/132) | 8.3 × 10-04 | - | - |
Gibberellic acid (up) | 39% (10/26) | 0.28 | - | - |
Gibberellic acid (down) | 61% (42/69) | 3.9 × 10-07 | - | - |
Indole-3-acetic acid (up) | 37% (108/295) | 2.9 × 10-02 | - | [7] |
Indole-3-acetic acid (down) | 47% (139/299) | 2.2 × 10-08 | - | - |
Methyl jasmonate (up) | 40% (242/611) | 5.9 × 10-06 | [56] | - |
Methyl jasmonate (down) | 48% (303/628) | 9.9 × 10-20 | [56] | - |
Salicylic acid (up) | 46% (153/331) | 7.0 × 10-09 | - | - |
Salicylic acid (down) | 41% (94/230) | 1.3 × 10-03 | - | - |
Cold | 41% (46/111) | 1.5 × 10-02 | - | [78] |
Heat | 53% (30/57) | 6.6 × 10-04 | - | - |
Osmoticum | 49% (18/37) | 2.0 × 10-02 | - | [78] |
Salt | 50% (62/124) | 1.1 × 10-05 | - | [78] |
Water deprivation | 51% (36/70) | 3.6 × 10-04 | - | - |